share_log

Needham Downgrades Surmodics to Hold

Benzinga ·  May 29 22:25

Needham analyst Mike Matson downgrades Surmodics (NASDAQ:SRDX) from Buy to Hold.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment